VN July 2021

Vetnuus | Julie 2021 36 Recent Clinically Relevant Research from Around theWorld CANINE Total injectable anaesthesia of dogs and cats for remote location veterinary Background Sterilisation clinics often occur in remote places where anaesthesia machines and compressed oxygen are unavailable. This study by Lisa Posner and associates describes the use of total injectable anaesthesia in dogs and cats presented for sterilisation in a remote location. Results A total of 100 animals were sterilised; 26 female cats (CF), 22 male cats (CM), 28 female dogs (DF), and 24 male dogs (DM). CF were anaesthetised with dexmedetomidine (20 mcg/kg), ketamine (8mg/kg) and hydromorphone (0.1mg/kg) IM. CM were anesthetised with dexmedetomidine (15 mcg/kg), ketamine (5mg/kg) and hydromorphone (0.1mg/kg) IM. Insufficient anaesthesia in cats was treated with alfaxalone (1mg/kg) IM. All cats were administered meloxicam at 0.3mg/kg SQ. DF were anesthetised with dexmedetomidine (15 mcg/kg), ketamine (7–10mg/kg) and hydromorphone (0.1mg/kg) IM. DMwere anesthetised with dexmedetomidine (15 mcg/kg), ketamine (5mg/kg) and hydromorphone (0.1mg/ kg) IM. All dogs had IV catheter and endotracheal tube placed. If SpO 2 <91%, ventilationwas assistedwith an Ambu bag. Insufficient anaesthesia in dogs was treated with alfaxalone (1mg/kg) IV. All dogs were administered meloxicam at 0.2mg/kg SQ. Following surgery, atipamezole (0.05– 0.1mg/kg) IM was administered to any patient that did not have voluntary movement. All patients survived and were discharged. Less than 25% of cats and male dogs required supplemental anaesthesia. Fifty-seven percent of female dogs required supplemental anaesthesia. More than 89% of patients (in any group) required atipamezole administration. One cat recovered with agitation and hyperthermia (41.1C/ 106F). Some dogs required ventilatory assistance to remain normoxemic while anesthetised. Conclusion Total injectable anaesthesia can be accomplished for remote location sterilisation clinics with minimal morbidity. https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02525-x v Background Buprenorphine is used for canine postoperative pain management. This study by Paulo Steagall and associates aimed to describe the pharmacokinetics and evaluate the analgesic efficacy of buprenorphine (Simbadol, 1.8mg/mL) administered by different routes in dogs undergoing ovariohysterectomy. Twenty-four dogs were included in a randomised, prospective, masked, clinical trial. Buprenorphine (0.02mg/ kg) was administered intravenously (IV), intramuscularly (IM) or subcutaneously (SC) ( n =8/group) 0.5h before general anaesthesia with propofol-isoflurane. Carprofen (4.4mg/kg SC) was administered after anaesthetic induction and before ovariohysterectomy. Pain was scored using the short-form Glasgow composite pain scale for dogs (SF-GCPS). Dogs were administered morphine (0.25mg/kg IV) when SF-GCPS scores were≥5/20. Blood sampling was performed up to 720min after drug administration. Plasma buprenorphine and norbuprenorphine concentrations were analysed using liquid chromatography mass spectrometry. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomised, prospective, masked, clinical trial

RkJQdWJsaXNoZXIy OTc5MDU=